BH3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 55.68 EUR -0.29%

Market Cap: €4.3B

	PTC Therapeutics Inc F:BH3	US
	Beyondspring Inc NASDAQ:BYSI	US
G	Global Compliance Applications Corp CNSX:APP	CA
B	Boryszew SA SWB:BOW	PL
	SBS Holdings Inc TSE:2384	JP
	Decibel Cannabis Company Inc OTC:DBCCF	CA
A	Avemio AG DUS:3D6	DE
O	Omico Corp XPHS:OM	PH
S	Sunbelt Rentals Holdings Inc LSE:SUNB	US
N	NSK Ltd DUS:NSK	JP

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

80%

Declining Gross Margin

94% > 93%

Healthy Operating Margin

12%

Sustainable 3Y Average Operating Margin

14%

Operating Margin is Increasing

-49% > 12%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-7%

Net Margin is Increasing

-80% > -4%

Negative Free Cash Flow Margin

-4%

Strong 3Y Average Free Cash Flow Margin

35%

Free Cash Flow Margin is Increasing

-37% > -4%

Positive ROE

21%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

30%

ROIC is Increasing

-34% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.